Ackermans & Van Haaren NV Overview
Ackermans & van Haaren is a 150-year-old, family-anchored Belgian investment holding. It positions itself as a long-term partner to family businesses and management teams.
Its value is concentrated in four core segments:
Marine Engineering & Contracting: DEME, a top-tier global dredging and offshore-wind installation contractor, and CFE, a Belgian/Luxembourg/Polish construction and development group.
Private Banking: Delen Private Bank and Bank J.Van Breda, jointly controlled with the Delen family, with €95.0bn of combined client assets at H1 2026.
Real Estate: Nextensa, a listed Brussels/Luxembourg mixed-use developer-investor.
Energy & Resources: SIPEF, an Indonesian/PNG palm-oil producer.
Around these sits a Growth Capital portfolio of minority and majority stakes. These include Life Sciences, India/South-East Asia, media, software and logistics, and, from Q4 2026, salmon aquaculture via Grieg Aqua.
AvH runs a debt-free holding with €524M net cash. It compounds equity per share at roughly 10% a year and pays a rising dividend.
Its equity-accounted and fully consolidated structure means reported IFRS revenue (about €6bn) understates economic exposure and overstates construction weight relative to value. Value is dominated by the private banks and DEME.
Company's own description (paraphrased from the FY2025 and H1 2026 press releases)
AvH describes itself as a diversified group active in four core sectors. In its Growth Capital segment it additionally provides growth capital to sustainable companies across sectors. Its stated ambition is to be the "long-term partner of choice of family businesses and management teams" (FY25 PR boilerplate).
The four core sectors are:
Marine Engineering & Contracting: DEME, described as a world leader in dredging, marine infrastructure and offshore-energy solutions, and CFE, active in real estate development, multitechnics and construction.
Private Banking: Delen Private Bank, with offices in Belgium, the Netherlands, Luxembourg, Switzerland and the UK through JM Finn, and Bank Van Breda, a niche bank for entrepreneurs and liberal professions in Belgium.
Real Estate: Nextensa, a listed mixed real estate investor and developer.
Energy & Resources: SIPEF, an agro-industrial group in tropical agriculture.
The group aims to build high-performing market leaders and contribute to a more sustainable world.
Independent characterisation
AvH is best understood as a permanent-capital conglomerate. It holds controlling or joint-controlling stakes, typically 40–80%, in a small number of large operating companies.
How it influences its holdings
-
AvH exercises influence through board seats, audit/risk committee participation and capital-allocation discipline.
-
It does not use central operational integration. Its model is explicitly "decentralised", with ESG and operations owned by local management (FY25 PR).
Revenue model at consolidated (IFRS) level — 2025 revenue of €5,961.6M breaks down as follows (FY25 PR income statement):
-
Revenue from construction contracts (DEME, CFE, Agidens, Biolectric): €5,271.3M, or 88.4%. This is project-based service revenue.
-
Interest income from banking activities (Bank Van Breda): €269.5M, or 4.5%.
-
Fees and commissions from banking activities: €144.0M, or 2.4%.
-
Real estate revenue (Nextensa rental and development sales, CFE/BPI development): €199.5M, or 3.3%.
-
Other operating revenue: €77.3M, or 1.3%.
Equity-accounted earnings are central. Equity-accounted earnings are not in revenue but are central to profit. They totalled €316.2M in 2025, versus €257.0M in 2024. The largest items are:
-
Delen Private Bank: €203.2M contribution.
-
SIPEF.
-
Mediahuis.
-
OMP.
-
Turbo's Hoet Groep.
-
V.Group.
-
Rentel/SeaMade.
As a result, profit is far more balanced than revenue. In 2025, Private Banking contributed 48% of core-segment profit while generating under 7% of consolidated revenue.
Value chain position by segment
-
DEME is a tier-1 EPCI (engineering, procurement, construction, installation) and marine contractor. Its clients are utilities and offshore-wind developers, port authorities and governments.
-
CFE is a general contractor, technical-installations provider (VMA, MOBIX) and developer (BPI Real Estate).
-
The banks provide discretionary wealth management, estate planning and niche lending to affluent private clients and professionals.
-
Nextensa develops and owns urban mixed-use real estate.
-
SIPEF is an upstream plantation operator selling crude palm oil (CPO), palm kernel products and bananas.
Customer types and end-markets
-
Offshore wind: Europe, US East Coast, Taiwan, Japan.
-
Port/dredging and coastal protection: global.
-
Environmental remediation: Benelux.
-
Belgian/Luxembourg/Polish construction and real estate.
-
Belgian, Dutch, Swiss, Luxembourg and UK wealth management.
-
Global vegetable-oil and European banana markets.
-
Supply-chain software (OMP), maritime services (V.Group), media (Mediahuis), commercial vehicles (Turbo's Hoet), chemical logistics (Van Moer), Indian consumer foods (VKC Nuts) and life-sciences venture.
Product vs. service mix (analyst classification of 2025 IFRS revenue)
| Revenue type (FY2025, EUR Mn) | Amount | % of total |
|---|---|---|
| Project/service revenue (construction contracts) | 5,271.3 | 88.4 |
| Banking interest income (gross) | 269.5 | 4.5 |
| Banking fees and commissions | 144.0 | 2.4 |
| Real estate (rental and sales) | 199.5 | 3.3 |
| Other operating revenue | 77.3 | 1.3 |
| Total | 5,961.6 | 100.0 |
Source: FY25 PR, consolidated income statement. Percentages are analyst-computed.
Strategy
Stated strategic themes (paraphrased from FY2025 Annual Results, H1 2026 and AR2025)
-
Long-term partner of choice. AvH acts as a permanent, family-anchored shareholder that backs entrepreneurial families and management teams to build market leaders. Examples: the Delen family (since 1992), the Grieg family (2026) and the Jain family (VKC Nuts, 2025).
-
Concentration on four core segments, plus a Growth Capital incubator. Successful growth investments can graduate to core status. Grieg Aqua is explicitly framed as building a Food & Agri platform anchored by SIPEF.
-
Active, decentralised ownership. AvH participates in audit and risk committees at DEME and CFE. It runs portfolio-wide cybersecurity self-assessments, an innovation-governance programme (including AI) and a talent-management programme (H1-26 PR).
-
Sustainability as value driver. The ESG priorities are Responsible Shareholder, Climate Change, Energy Transition and Talent Management. ESG due diligence covered 100% of new investments in 2025.
-
Conservative capital structure. Investments are equity-financed. The holding carries no debt, and the rising dividend is funded by upstreamed dividends.
-
Compounding equity per share. Growth was about 10% a year: 10.3% in 2025, and 6.15% in H1 2026 including the dividend.
Strategic initiatives, last 24 months (Oct-2024 to Oct-2026)
| Initiative | Entity | Date | Detail |
|---|---|---|---|
| Updated Delen family shareholder pact | AvH / Delen | Nov-2024 | Share-transfer provisions, enhanced governance rights and higher dividend distributions (TipRanks/Nasdaq summary of AvH PR) |
| Havfram acquisition and fleet expansion | DEME | Apr-2025 to 2026 | Two next-generation wind-installation vessels; cable vessel ordered (delivery 2028); 22,000 m³ TSHD (2029) |
| Private-banking external growth | Delen | 2025–2026 | Dierickx Leys, Petram & Co, Servatus, Box Consultants, Van Lawick (pending) |
| Nextensa repositioning | Nextensa | 2025–2026 | Disposals (Knauf, Diekirch, Monteco, Retail Estates stake, Stadlau, Stairs, B&B Hotels) recycled into Lake Side, BEL Towers, Treemont and Cloche d'Or |
| India / SE Asia platform | AvH Growth Capital | 2025–2026 | VKC Nuts; Venturi Fund II ($20M commitment); Medikabazaar rights issue |
| Life Sciences follow-ons | AvH | 2025–2026 | DISCO seed (co-led), MRM Series B (€3M), Biotalys placement (€2.5M) |
| Food & Agri platform | AvH | Aug-2026 | Grieg Aqua, €93M for 37.5% |
| Battery storage | GreenStor / BSTOR | 2025–2026 | D-STOR and ESTOR-LUX II, more than €200M combined; TINC/Infravest co-investment of €22M |
| Selective tendering / risk discipline | CFE | 2025–2026 | Construction & Renovation margin rose to 5.7% in H1-26, a historic high |
| SIPEF GHG reduction plan | SIPEF | 2,025 | SBTi-inspired 2030 targets; methane capture; bio-CNG (first production H1 2026) |
Guidance and targets (latest)
| Entity | Guidance | Source |
|---|---|---|
| AvH group | FY2026 net profit growth of more than 10% versus €592.5M, barring unforeseen circumstances (upgraded from "roughly in line" in February/May 2026) | H1-26 PR |
| DEME | 2026 turnover slightly above 2025; EBITDA margin in line with 2025; capex about €450M. 2027 EBITDA broadly in line with 2025 despite a somewhat lower top line | H1-26 PR |
| CFE | 2026 ROE of at least 10% | H1-26 PR |
| Delen / Van Breda | Further improvement of FY2026 results versus 2025, barring adverse markets | H1-26 PR |
| SIPEF | About 470,000 t CPO in 2026; recurring result above the 2025 record; capex $100–120M funded from operating cash flow | H1-26 PR |
| Nextensa | Rental income dip in H2 2026; Proximus move from 1-Jan-2027 lifts rents; €100M bond (Nov-2026) refinanced from €205M of undrawn lines | H1-26 PR |
Formal targets. No formal multi-year medium-term group financial targets (for example, ROE or NAV growth targets) are published.
Products & Services
AvH is a holding company, so its "products" are those of its participations. They are catalogued by segment and company below.
Marine Engineering & Contracting
DEME (AvH 62.1%)
| Business line | Description and capabilities | Target customer | Flagship assets / projects | FY2025 revenue (EUR Mn) |
|---|---|---|---|---|
| Offshore Energy | Transport and installation of wind-turbine foundations (monopiles up to about 3,000 t, jackets) and turbines, inter-array and export cables, rock placement, substations, O&M support | Offshore-wind developers and utilities (Dominion, Equinor, Ørsted, Vestas, etc.) | Norse Wind and Norse Energi (ex-Havfram jack-ups for >300 m rotors, 70 m water depth, in service 2026); Green Jade; Apollo (multi-year Vestas O&M deployment); new cable vessel due 2028. Projects: Coastal Virginia, Vineyard Wind, Empire Wind 1, Hai Long, Fengmiao, Dieppe-Le Tréport, Baltic Power, Dogger Bank, IJmuiden Ver, Nordlicht 1, Zeevonk | 2,133.5 |
| Dredging & Infra | Capital and maintenance dredging, land reclamation, coastal protection, immersed tunnels, marine civil works | Port authorities, governments, energy terminals | Princess Elisabeth Island (BE), Oosterweel tunnel (BE), Fehmarnbelt (DK/DE), Port-La Nouvelle (FR), Cuxhaven terminal (DE). New 22,000 m³ TSHD ordered July 2026 (delivery 2029) | 1,952.3 |
| Environmental | Soil and groundwater remediation, PFAS, dike reinforcement, soil treatment centres, activated-carbon filtration (Cargen JV) | Public authorities, industry | Lekdijk reinforcement (NL), Schiphol PFAS remediation (from H2 2026), former ArcelorMittal Liège site | 271.8 |
| Concessions | Equity stakes in offshore wind (C-Power, Rentel, SeaMade), ScotWind Bowdun (70%), ports (Duqm Oman, Port-La Nouvelle, Paranaguá Brazil 25-year access-channel concession) | Infrastructure investors | Blankenburg Tunnel stake sold in 2026 (gain €2.6M) | 3.7 |
| GSR (Global Sea Mineral Resources) | Deep-sea polymetallic nodule exploration. MoU with Japan's DORD for a pilot mining test (H1 2026) | Future metals supply | Regulatory monitoring | — |
| HYPORT Energy | Green-molecule (hydrogen/ammonia) project platform in Oman and Egypt | Energy offtakers | Development stage | — |
FY2025 key figures: turnover €4,154.7M, EBITDA €930.5M (22.4% margin), net profit €346.3M (FY25 PR).
CFE (AvH 62.5%)
| Division | Description | FY2025 turnover (EUR Mn) | Flagships |
|---|---|---|---|
| Real Estate Development (BPI Real Estate) | Residential, office and mixed-use development in Belgium, Luxembourg and Poland. Portfolio €220M at YE25 (€214M at H1-26). Pipeline sales value €1.62bn / 358,000 m² | 76.7 | Brouck'R (Brussels), EQ (fully let to the European Commission), Kennedy Park Luxembourg (KPMG and Linklaters HQs from 2028), Cavallia (Poznan), Piano Forte (Warsaw) |
| Multitechnics | VMA (electrical/HVAC/automation for data centres, hospitals, industry) and MOBIX (rail signalling, catenary, cabling, public lighting) | 301.4 | Data-centre and hospital installations. LUWA project losses at MOBIX |
| Construction & Renovation | General contracting in Belgium, Luxembourg and Poland | 683.4 | Oosterweel, INEOS One, SD Worx HQ, PwC and Luxembourg Red Cross HQs, NATO-site housing in Mons, Kanal-Pompidou |
| Investments & Holding | 50% of Deep C Holding and Green Offshore | -20.0 (eliminations) | — |
FY2025 key figures: turnover €1,041.6M, net profit €33.5M.
Deep C Holding (AvH 81.3%)
-
Industrial-zone developer in northern Vietnam. 81 ha of land sold in 2025.
-
FY2025 turnover €60.5M and net profit €10.5M.
-
LG Innotek chose a Deep C zone in July 2026 for a semiconductor-substrate plant of about 24 ha.
Green Offshore (AvH 81.3%)
-
Holds stakes in Rentel (309 MW) and SeaMade (487 MW) offshore wind farms in Belgium.
-
Production was 2.6 TWh in 2025.
-
AvH's look-through beneficial capacity, including via DEME, is 155 MW.
Private Banking
| Entity | Offering | Clients | Key data | Pricing model |
|---|---|---|---|---|
| Delen Private Bank (78.75%) | Discretionary portfolio management (90–91% of AuM), patrimonial funds, estate and succession planning, integrated "Family & Wealth" approach | Affluent and HNW private clients in Belgium, the Netherlands, Luxembourg and Switzerland | Consolidated AuM €76.4bn (YE25) and €84.2bn (H1-26). Cost-income ratio 41% at Delen Continental. ROE 20.8% (2025) | Fee-based. Gross fees and commissions about 1.04–1.05% of average AuM (combined) |
| JM Finn (UK, within Delen) | Discretionary and advisory wealth management | UK private clients | AuM €14.9bn (H1-26). 6 offices after Cheltenham opened (2026). Cost-income ratio 84% | Fee-based |
| Delen Private Bank Netherlands | Same model, acquisitive build-out (8 acquisitions in 10 years, including Oyens & Van Eeghen, Box Consultants, Petram & Co, Servatus and Van Lawick (pending)) | Dutch HNW clients | AuM €4.98bn (H1-26), trending towards €6bn | Fee-based |
| Bank J.Van Breda & C° (78.75%) | Niche bank for entrepreneurs and liberal professions: deposits, lending (loan book about €6.5bn), off-balance investments (€24.0bn), routed largely to Delen mandates (€21.3bn) | Belgian entrepreneurs, doctors, lawyers and other professionals | 30 offices. Net profit €106.4M (2025). ROE 12.3%. Net Promoter Score 66 | Net interest margin plus fees |
Real Estate — Nextensa (AvH 69.3%)
| Product line | Description | Flagships |
|---|---|---|
| Investment properties | Portfolio worth €1,062.4M (H1-26) in Belgium and Luxembourg. Retail parks and Knauf centres largely sold | Tour & Taxis (Brussels), Moonar (Luxembourg) |
| Development | Mixed-use urban development | Lake Side at Tour & Taxis (38,000 m² Proximus HQ fully pre-let plus a residential tower; about €265M construction). BEL Towers (former Proximus HQ, 115,000 m²; about €300M). Treemont (EIB usufruct). Cloche d'Or JV (Grossfeld 50%: The Rock, Terraces for Lombard Odier, Eosys for PwC/Franklin Templeton, D5-D10 residential) |
Energy & Resources
| Entity | Products | Key specs (FY2025) |
|---|---|---|
| SIPEF (43.3%) | Sustainable crude palm oil (CPO), palm kernel products, bananas (Côte d'Ivoire), bio-CNG | 441,867 t palm oil (+21.9%). 52,159 t bananas. 9 of 10 mills RSPO-certified, 100% traceable. Halal certification on all Indonesian mills. Average ex-mill price $955/t (2025) and $1,007/t (H1-26) |
| Verdant Bioscience (42%) | F1-hybrid oil-palm seeds | First commercial seeds targeted for 2029 |
| Sagar Cements (19.6%) | Cement (South and East India) | Turnover INR 24.7bn (2025). Capacity utilisation 57%. Jeerabad plant expanded to 1.5 Mtpa in June 2026 |
AvH & Growth Capital — participations
| Company (stake) | Product / service | FY2025 key data |
|---|---|---|
| Agidens (82.7%) | Industrial automation, digital solutions, validation and testing, life-cycle services (pharma, food, infrastructure). AUGI (Spain) | Revenue €74.4M. Net €3.2M (record) |
| Biolectric (54.3%) | On-farm biogas CHP units and biomethane purification for grid injection | Revenue €16.9M. Net -€0.4M. Record order book €59.3M. More than 40 installations in 2025 |
| Camlin Fine Sciences (8.8%) | Shelf-life antioxidants and blends, vanillin (Dahej, India), diphenol derivatives. Vinpai acquisition (Dec 2025) | Vanillin sales doubled. US 50% tariff headwind |
| GreenStor (50%) | 38% of BSTOR, Belgian battery storage: D-STOR (140 MWh) and ESTOR-LUX II (270 MWh). TINC and Infravest co-investment (Jul-2026) | Net -€1.2M |
| Mediahuis (14.4%) | News brands (Belgium, Netherlands, Ireland, Luxembourg, Germany), radio, digital marketplaces | Revenue €1,257.9M. Net €156.9M (incl. capital gain on AMV) |
| OMP (20%) | Unison Planning™ supply-chain planning SaaS. UnisonIQ AI agents. Gartner MQ Leader for the 11th time (2026) | Turnover €247.7M (+12%). EBITDA margin 23%. Net €43.3M |
| Turbo's Hoet Groep (50%) | DAF and other truck dealerships, TH Lease (5,446 vehicles), turbo remanufacturing | Turnover €665.1M. Net €7.7M |
| V.Group (33.3%) | Ship management (V.Ships), maritime services (V.Services). Njord decarbonisation. About 3,500 vessels and 44,000 seafarers | Turnover $713.1M. EBITDA $72.7M |
| Van Moer Logistics (32.4%) plus Blue Real Estate (33.3%) | Intermodal and chemical logistics, Polymer Hub silos (Port of Antwerp-Bruges), Beringen platform, air freight (ex-Ziegler Belgium, Jun-2026) | Revenue €343.6M. Net €6.3M |
| VKC Nuts (16.6%; 18.2% look-through) | Nuts and dried fruit under the "Nutraj" brand. 6 plants in India | Turnover about €160M (FY to Mar-2025) |
| Gravity Media (22.7%) | Broadcast production services (merged with EMG) | Impaired €7.6M in H2 2025 |
AvH & Growth Capital — fair-value clusters
| Company (stake) | Status / focus |
|---|---|
| AstriVax (7.7%) | HPV therapy |
| Biotalys (15.7–16.3%) | EVOCA™ biocontrol, EPA-approved Dec-2025 |
| Confo Therapeutics (6.2%) | GPCR drugs. CFTX-1554 licensed to Eli Lilly, in Phase 2a |
| DISCO Pharmaceuticals (10.9%) | Amgen licence worth up to $618M |
| MRM Health (14.7%) | MH002, FDA Fast Track for ulcerative colitis |
| OncoDNA (about 10%) | Cancer biomarker tests and genomic services |
| VICO Therapeutics (10.3%) | Antisense platform, Huntington's disease |
| Indigo Diabetes (2.8%) | — |
| Bio Cap Invest (22.6%) | — |
| Company (stake) | Status / focus |
|---|---|
| HealthQuad I (36.3%) and HealthQuad II (11.0%) | Indian healthcare funds |
| Medikabazaar (about 22% direct and indirect, after the 2026 rights issue) | B2B healthcare distribution |
| Venturi Partners Fund I (11.1%) and Fund II (14.0%; $20M commitment) | Consumer funds, India and SE Asia |
| Convergent Finance (6.3%) | Platform for listed Indian companies |
Life Sciences
India & South-East Asia
Pending (Q4 2026)
Grieg Aqua AS (37.5%, €93M): holding company owning 50.17% of Oslo-listed Grieg Seafood ASA, a salmon farmer focused on Rogaland, Southwest Norway.
- Grieg Seafood had a market capitalisation of NOK 3.4bn (27-Aug-2026). Its Rogaland operations generated operational EBIT of NOK 433M in 2025.
Financial Narrative
Income statement
Sources and derivations
-
Revenue FY2021–2023 and S&P rows: S&P/SA.
-
FY2024–2025: FY25 PR.
-
Net result FY2021–2022: FY22 PR. FY2023: FY25 PR.
-
Pre-tax FY2021–2023 is derived from S&P/SA pre-tax margins (13.77%, 20.21%, 11.67%) and is approximate.
Margins
Growth rates
-
Revenue CAGR FY2021–FY2025: about 8.5% (analyst-computed, 4,297 to 5,961.6).
-
Group-share net income CAGR: about 9.9% (406.8 to 592.5).
-
Ten-year compounded equity-per-share growth, as reported by AvH at FY2023: 9.8%.
Balance sheet
Sources and derivations
-
FY25 PR consolidated balance sheet and key figures; FY22 PR; AvH 2023 results PR.
-
Net financial debt = total financial debt (including leases) minus cash and equivalents. It excludes Bank Van Breda deposits and loans.
H1 2026 balance sheet update
-
Equity, group share: €5,898.5M.
-
Equity per share: €180.58.
-
AvH net cash: €524.4M.
-
Total assets: €21,260.6M.
-
Financial debt: €1,363.2M non-current and €538.6M current.
-
Cash: €1,480.4M.
Cash flow
Sources and notes
-
FY2024–2025: FY25 PR. FY2021–2023: S&P/SA.
-
Operating cash flow includes the working-capital movements of Bank Van Breda's balance sheet, which distorts year-on-year comparisons. For example, the FY2024 operating cash flow of €1,410M included +€465M of bank deposit growth.
Ratios (analyst-derived unless noted)
ROIC and the cash conversion cycle are not disclosed and are not meaningful for a mixed bank and industrial holding.
Trend commentary
Revenue
-
Consolidated revenue grew from €4.3bn (2021) to a peak of €6.04bn (2024), almost entirely through DEME. DEME turnover went from €2.7bn (2022) to €4.15bn (2025), per the FY25 PR.
-
The slight 2025 decline (-1.4%) reflects CFE's 11.9% drop in construction turnover and lower Nextensa real estate revenue after disposals. These offset DEME's +1%.
-
H1 2026 revenue was flat at €3,030.2M.
Profit quality
-
2022's €708.7M was inflated by €326.4M of net capital gains (Anima, Manuchar).
-
By contrast, 2025's net capital result was negative €5.8M (Gravity Media impairment). The FY2025 result is therefore recurring in nature.
-
Net result before capital gains rose from €373.5M (2023) to €598.3M (2025), a 26.6% CAGR.
Operating leverage
-
Derived EBITDA margin widened from 15.5% to 20.2% in 2025.
-
DEME's EBITDA margin rose to 22.4% (Offshore Energy at 30.7%), and banking cost-income was stable at 49%.
Balance sheet
-
The holding has carried no financial debt at the AvH & subholdings level since at least 2022. Holding net cash was €428.9M at year-end 2025 and €524.4M at H1 2026, with treasury shares included at €90.7M.
-
Consolidated debt rose in 2025 because of DEME's €1,066M investment year, which included Havfram. DEME's net financial debt was €391M at year-end 2025, then €291M at H1 2026, or 0.3x EBITDA.
Cash flow
-
Free cash flow is lumpy because of DEME fleet capex and bank balance-sheet flows.
-
Upstream dividends to AvH were €295.3M in 2025 (€210.7M from the banks) and €282.7M in H1 2026 alone (€186.0M from the banks). These comfortably cover AvH's dividend outflow of €124.4M in 2025 and €150.3M in 2026.
Dividends
-
The gross dividend has compounded at about 14% a year from €2.75 (FY2021) to €4.60 (FY2025).
-
The FY2025 payout is about 25% of group-share EPS, conservative by holding-company standards.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Content and consolidation method (stake at 30-Jun-2026) |
|---|---|
| DEME Group (full consolidation, 62.12%); CFE (full, 62.54%, up from 62.12% at YE25); Deep C Holding (full, 81.27%); Green Offshore (full, 81.27%; holds Rentel and SeaMade stakes) |
| Delen Private Bank (equity method, 78.75%, joint control with the Delen family); Bank J.Van Breda & C° (full, 78.75%); FinAx (full, 100%) |
| Nextensa (full, 69.28%; 63.39% at YE24 and 68.81% at YE25) |
| SIPEF (equity method, 43.32%; 41.10% at YE24 and 42.20% at YE25); Verdant Bioscience (equity, 42%); AvH India Resources (full, 100%); Sagar Cements (equity, 19.64%) |
| Holding and subholdings. Fully consolidated: Agidens (82.7%) and Biolectric (54.3%). Equity method: Amsteldijk Beheer, Gravity Media, GreenStor, Mediahuis Partners/Mediahuis, MediaCore, OMP, Turbo's Hoet Groep, Van Moer Logistics, Blue Real Estate, Camlin Fine Sciences, V.Group, VKC Nuts. Fair-value Life Sciences and India/SE Asia clusters |
Revenue by Segment and Segment Margins & Growth (%)
| Segment (EUR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Marine Engineering & Contracting | 128.5 | 201.8 | 241.9 |
Private Banking | 208.7 | 258.5 | 287.4 |
Real Estate | 15.6 | -6.4 | 23.5 |
Energy & Resources | 24.6 | 20.6 | 41.3 |
Contribution from core segments | 377.4 | 474.5 | 594.1 |
Growth Capital | 10.9 | -8.6 | 26.3 |
AvH & subholdings | -14.8 | -9.9 | -22.0 |
Net result before capital gains | 373.5 | 456.1 | 598.3 |
Net capital gains (losses) | 25.7 | 3.8 | -5.8 |
Consolidated net result (group share) | 399.2 | 459.9 | 592.5 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Segment metric | FY2024 | FY2025 |
|---|---|---|
MEC contribution YoY growth (%) | 57.0 | 19.9 |
Private Banking contribution YoY growth (%) | 23.9 | 11.2 |
Energy & Resources contribution YoY growth (%) | -16.3 | 100.5 |
MEC share of core contribution (%) | 42.5 | 40.7 |
Private Banking share of core contribution (%) | 54.5 | 48.4 |
Real Estate share of core contribution (%) | -1.3 | 4.0 |
Energy & Resources share of core contribution (%) | 4.3 | 7.0 |
Segment revenue (EUR Mn)
| Segment revenue (EUR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Marine Engineering & Contracting | 3,783 | 3,965 | 4,654 | 5,394 | 5,329 |
Private Banking | 205.0 | 217.5 | 346.6 | 420.2 | 415.1 |
Real Estate | 237.4 | 145.1 | 127.9 | 135.7 | 124.5 |
AvH & Growth Capital | 89.5 | 75.7 | 95.4 | 95.8 | 95.5 |
Energy & Resources | 0.02 | 0.03 | 0.04 | 0.04 | 0.48 |
Total (incl. eliminations) | 4,312 | 4,401 | 5,222 | 6,043 | 5,962 |
Revenue by Segment and Segment Margins & Growth (%) (Half-Yearly)
| Segment (EUR Mn) | H1-2024 | H1-2025 | H1-2026 |
|---|---|---|---|
Marine Engineering & Contracting | 90.4 | 117.0 | 140.2 |
Private Banking | 116.2 | 134.3 | 148.0 |
Real Estate | 9.5 | 13.9 | 12.3 |
Energy & Resources | 8.1 | 19.6 | 22.3 |
Core segments | 224.2 | 284.7 | 322.8 |
Growth Capital | -25.3 | -1.2 | 21.4 |
AvH & subholdings | 1.4 | -11.7 | -7.9 |
Net capital gains | 0.1 | 1.5 | 3.3 |
Consolidated net result | 200.4 | 273.2 | 339.6 |
Revenue by Segment and Segment Margins & Growth (%) by Participation Contribution
| Participation contribution (EUR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
DEME | 98.6 | 176.5 | 212.6 |
CFE (excl. Deep C and Green Offshore) | 6.8 | 8.4 | 15.6 |
Deep C Holding | 7.1 | 10.3 | 8.5 |
Green Offshore | 16.0 | 6.6 | 5.2 |
FinAx | 0.7 | 0.5 | 0.5 |
Delen Private Bank | 141.3 | 179.1 | 203.2 |
Bank Van Breda | 66.7 | 78.9 | 83.8 |
Nextensa | 15.6 | -6.4 | 23.5 |
SIPEF | 25.1 | 24.8 | 46.2 |
Verdant Bioscience | -1.3 | -1.3 | -1.6 |
Sagar Cements | 0.8 | -3.0 | -3.3 |
Growth Capital participations (consolidated and equity method) | 24.0 | 27.1 | 20.7 |
Growth Capital fair-value investments | -13.1 | -35.6 | 5.6 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (EUR Mn) | 4,297 | 4,401 | 5,222 | 6,043.3 | 5,961.6 |
Revenue growth (%) | 9.9 | 2.4 | 18.6 | 15.7 | -1.4 |
Gross profit (S&P, EUR Mn) | 1,623 | 1,552 | 1,883 | 2,236 | 2,434 |
Profit from operating activities, IFRS (EUR Mn) | — | — | — | 478.4 | 651.8 |
Operating income, S&P definition (EUR Mn) | 341.95 | 312.32 | 514.07 | 712.86 | 809.23 |
EBITDA, derived = IFRS op. profit + depreciation + impairments (EUR Mn) | — | — | — | 937.7 | 1,205.3 |
Share of profit of equity-accounted investments (EUR Mn) | — | — | — | 257.0 | 316.2 |
Pre-tax income (EUR Mn) | 591.7 | 889.4 | 609.4 | 744.2 | 946.5 |
Net income incl. minorities (EUR Mn) | — | — | — | 603.2 | 778.7 |
Net income, group share (EUR Mn) | 406.8 | 708.7 | 399.2 | 459.9 | 592.5 |
EPS basic (EUR) | — | — | 12.13 | 14.07 | 18.14 |
EPS diluted (EUR) | 12.26 | 21.37 | 12.12 | 14.05 | 18.10 |
Dividend per share, gross (EUR) | 2.75 | 3.10 | 3.40 | 3.80 | 4.60 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin metric
| Margin metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin, S&P (%) | 37.8 | 35.3 | 36.1 | 37.0 | 40.8 |
Operating margin, IFRS (%) | — | — | — | 7.9 | 10.9 |
Operating margin, S&P (%) | 8.0 | 7.1 | 9.8 | 11.8 | 13.6 |
EBITDA margin, derived (%) | — | — | — | 15.5 | 20.2 |
Pre-tax margin (%) | 13.8 | 20.2 | 11.7 | 12.3 | 15.9 |
Net margin, group share (%) | 9.5 | 16.1 | 7.6 | 7.6 | 9.9 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (EUR Mn) | — | — | — | 20,291.4 | 21,263.0 |
Cash and cash equivalents (EUR Mn) | — | — | 989.8 | 1,383.3 | 1,463.5 |
Financial debt, non-current (EUR Mn) | — | — | — | 1,207.5 | 1,516.6 |
Financial debt, current (EUR Mn) | — | — | — | 621.8 | 548.7 |
Total financial debt, excl. bank deposits (EUR Mn) | — | — | — | 1,829.3 | 2,065.3 |
Consolidated net financial debt, derived (EUR Mn) | — | — | — | 446.0 | 601.8 |
AvH holding-level net cash (EUR Mn) | 77.7 | 498.7 | 517.5 | 362.4 | 428.9 |
Equity, group share (EUR Mn) | 3,957.2 | 4,633.6 | 4,914.0 | 5,278.2 | 5,701.1 |
Minority interests (EUR Mn) | — | — | 1,463.1 | 1,537.9 | 1,618.8 |
Total equity (EUR Mn) | — | — | 6,377.1 | 6,816.1 | 7,319.9 |
Goodwill plus intangibles (EUR Mn) | — | — | — | 438.5 | 432.7 |
Working capital ex-bank items, derived (EUR Mn) | — | — | — | 740.4 | 959.2 |
Equity per share (EUR) | 119.37 | 139.96 | 150.25 | 161.58 | 174.45 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (EUR Mn) | 781.75 | 716.64 | 619.2 | 1,410.2 | 1,005.4 |
Capex, intangible and tangible (EUR Mn) | 319.02 | 514.53 | 433.99 | 310.16 | 469.43 |
Free cash flow, OCF minus capex (EUR Mn) | 462.73 | 202.11 | 185.21 | 1,100.0 | 536.0 |
Acquisition of subsidiaries (EUR Mn) | — | — | — | 16.5 | 534.5 |
Dividends paid by AvH (EUR Mn) | — | — | — | 111.3 | 124.4 |
Dividends paid to minorities (EUR Mn) | — | — | — | 38.9 | 51.4 |
Net treasury-share purchases, AvH (EUR Mn) | — | — | — | 10.2 | 4.6 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, group share, on average equity (%) | 10.8 | 16.5 | 8.4 | 9.0 | 10.8 |
ROE as reported by AvH, equity-per-share growth incl. dividend (%) | — | — | — | — | 10.3 |
ROA, group share, on average assets (%) | — | — | — | — | 2.9 |
Debt / total equity (x) | — | — | — | 0.27 | 0.28 |
Net financial debt / derived EBITDA (x) | — | — | — | 0.48 | 0.50 |
Interest coverage, IFRS op. profit / non-bank interest expense (x) | — | — | — | 7.5 | 11.4 |
Current ratio ex-bank items (x) | — | — | — | 1.20 | 1.26 |
Asset turnover, revenue / average assets (x) | — | — | — | — | 0.29 |
Participation Details
| Participation | Geographic profile (latest) |
|---|---|
DEME (89% of MEC revenue weight) | Europe is more than half of 2025 turnover. The Americas are the second-largest market, with significant growth from US East Coast offshore wind. Asia shows robust growth (Taiwan offshore, regional dredging). Order book YE25: Europe 78% (+3% YoY), Americas down from 12% to 7% (FY25 PR) |
CFE | Belgium is dominant. Luxembourg turnover rose 38% in 2025, Belgium fell 12.5% and Poland fell 35%. In H1 2026 Luxembourg rose strongly while Belgium and Poland declined |
Delen / JM Finn | AuM YE25: Delen Continental (BE/NL/LU/CH) €62.8bn, of which the Netherlands is €4.66bn. JM Finn (UK) €13.6bn |
Bank Van Breda | 100% Belgium (30 offices: 20 Flanders, 3 Brussels, 7 Wallonia) |
Nextensa | Belgium (Tour & Taxis, Brussels) and Luxembourg (Cloche d'Or). Austria exited (Stadlau sold Jan-2026) |
SIPEF | Indonesia (North Sumatra, South Sumatra, Bengkulu), Papua New Guinea, Côte d'Ivoire (bananas) |
Deep C | Vietnam |
Sagar, VKC, Camlin, Medikabazaar, HealthQuad, Venturi | India and South-East Asia |
Grieg Aqua (pending) | Norway |
Revenue by Region (%) and Region Margins & Growth (%)
| Geographic metric | FY2024 | FY2025 |
|---|---|---|
DEME order book share, Americas (%) | 12 | 7 |
CFE Luxembourg turnover growth (%) | — | 38 |
CFE Poland turnover growth (%) | — | -35 |
CFE Belgium turnover growth (%) | — | -12.5 |
Delen Netherlands AuM (EUR Mn) | 3,440 | 4,660 |
JM Finn UK AuM (EUR Mn) | 13,105 | 13,606 |
Share price metric (EUR)
| Share price metric (EUR) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Year-end closing price | 158.8 | 190.5 | 232.0 |
Annual high | 165.5 | 193.1 | 235.6 |
Annual low | 136.8 | 153.2 | 179.4 |
Calendar-year price return (%) | — | 20.0 | 21.8 |
Valuation Multiples
| Multiple | AvH | Note |
|---|---|---|
P/E, trailing 12 months (x) | 13.1 | S&P/SA; TTM EPS €20.11 |
P/E on FY2025 basic EPS (x) | 14.4 | 262 / 18.14 |
P/B on H1-26 equity per share (x) | 1.45 | 262 / 180.58 |
EV/EBITDA (x) | 9.0 | EV of about €10.8bn = market cap €8.56bn + minorities €1.66bn + consolidated net financial debt of about €0.6bn, over derived EBITDA €1.205bn. Distorted by equity-accounted Delen |
EV/Sales (x) | 1.8 | Same caveat |
Dividend yield (%) | 1.76 | €4.60 / €262 |
Source Details
| Source | Analysts | Rating | Average target (EUR) |
|---|---|---|---|
S&P/SA | 7 | Buy | 315.71 |
MarketScreener (via ad-hoc-news) | 6 | — | 311.86 |
Dividend metric
| Dividend metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
Gross DPS (EUR) | 2.35 | 2.75 | 3.10 | 3.40 | 3.80 | 4.60 |
DPS growth (%) | — | 17.0 | 12.7 | 9.7 | 11.8 | 21.1 |
Net DPS after 30% withholding (EUR) | — | — | — | 2.38 | 2.66 | 3.22 |
Analyst Conclusions
Guidance summary
AvH: FY2026 net profit growth above 10%, implying more than €651.8M (H1-26 PR).
DEME: 2026 turnover slightly above 2025 at a stable EBITDA margin, and 2027 EBITDA broadly in line with 2025.
SIPEF: a record recurring result.
Banks: higher full-year results.
CFE: ROE of at least 10%.
Nextensa: recovery in 2027 rental income.
Consensus growth. S&P/SA shows a forward P/E of 13.4x versus 13.1x trailing. This implies consensus FY2026–27 EPS broadly in line to modestly up from the TTM level. S&P/SA also notes revenue forecast to stay roughly flat over the next 3 years.
Bull case
-
Banks as a compounding engine. Client assets of €95bn (+9% in H1) at a stable 1.04% fee margin and 49% cost-income ratio support double-digit profit growth. Dutch M&A (Van Lawick, Breda office) and new Belgian offices extend the runway.
-
DEME's fleet investment cycle is complete. With Norse Wind and Norse Energi delivered, capex normalises to about €450M while EBITDA holds above €900M. Free cash flow was €231M in H1-26 and net debt/EBITDA 0.3x. This enables higher DEME dividends to AvH.
-
Optionality from net cash and growth capital. €524M of net cash, a Growth Capital turnaround (+€21.4M in H1-26) and platform deals (Grieg, VKC) add earnings legs. Life Sciences validation (DISCO–Amgen) could crystallise gains.
Bear case
-
Offshore-wind order intake slows. DEME's Offshore Energy backlog fell to €3.7bn, and DEME itself guides a lower 2027 top line. US policy and investment-timing lags could compress utilisation and margins from the exceptional 30%+ seen in 2025.
-
Market and commodity reversal. An equity-market correction would hit AuM fees directly. A palm-oil price normalisation from $1,000+/t would reverse SIPEF's doubling of contribution.
-
The holding discount persists. At 1.45x book but with no published NAV, a family-controlled structure and a 1.8% yield, the shares derated from €300 to €262 even as H1 profit rose 24%. Capital deployed into salmon (a stated "transition year") and sub-scale minorities may dilute returns.
Key catalysts and monitorables (next 12 months)
| Date / period | Catalyst |
|---|---|
| Q4-2026 | Closing of Grieg Aqua (and the outcome of any mandatory-offer process) and Delen–Van Lawick |
| 1-Dec-2026 | Q3 2026 interim statement: watch DEME order intake versus the €7.1bn backlog and bank inflows |
| Nov-2026 | Nextensa €100M bond repayment |
| 1-Jan-2027 | Proximus relocation to Tour & Taxis |
| 26-Feb-2027 | FY2026 results versus the above +10% guidance; the FY2026 dividend proposal (a sixth consecutive increase is likely given cover) |
| H1-2027 | Deep C land sales recovery (LG Innotek); SIPEF production versus 470 kt; El Niño |
| Ongoing | US offshore-wind policy; Middle East (Duqm); EUR/USD; Biotalys financing runway (end-Q1 2027) |
Analyst verdict
Ackermans & van Haaren enters the final quarter of its 150th-anniversary year in the strongest operating condition in its modern history.
The results. FY2025 delivered €592.5M of almost entirely recurring net profit. H1 2026 added €339.6M (+24%), and management has upgraded full-year guidance to growth above 10%.
Earnings quality. It is high. Two-thirds of core profit comes from the two private banks and DEME. All three posted record results while maintaining fortress balance sheets: combined bank CET1 of 25.4%, and DEME at 0.3x net debt/EBITDA.
Capital allocation. The debt-free holding, with €524M of net cash and dividends upstreamed at nearly twice its own payout, gives AvH unusual freedom. Its record of compounding equity per share at about 10% a year is credible and well-documented.
The tension: valuation versus trajectory. At €262, the shares trade at about 13–14x earnings and 1.45x book. That is undemanding for a business compounding at 10%+, but the 2026 derating from €300 shows investors already price peak-cycle concerns. These centre on two things:
-
DEME's shrinking Offshore Energy backlog.
-
The sustainability of palm-oil prices.
The new salmon investment is strategically coherent with SIPEF but arrives in a self-declared transition year. It adds execution risk rather than near-term earnings.
Our synthesis. AvH remains a high-quality, family-controlled compounder whose downside is cushioned by the annuity-like banking franchise and holding liquidity. Upside depends on three things:
-
DEME converting tender pipelines (Asia, North Sea, Brazil) into a backlog recovery in 2027.
-
Delen sustaining inflows above €7bn a year.
-
Growth Capital proving it can repeat its 2022-style exits.
Absent a published NAV or more aggressive capital returns, the holding discount is likely to persist. The risk/reward favours patient, long-horizon investors over those seeking re-rating catalysts.
On balance, the evidence supports a constructive stance, consistent with the consensus "Buy" and targets of about €312–316. This is tempered by cyclical exposure that argues against chasing the shares toward their highs.
Prepared from public sources as of 19-Oct-2026. "Not publicly disclosed" denotes information absent from the sources reviewed, not necessarily absent from the full Annual Report.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Born | Tenure / background |
|---|---|---|---|
John-Eric Bertrand | Co-CEO; Co-Chairman of the Executive Committee | 1,977 | At AvH since 2008 (GlobalData). Co-CEO since the 2022 succession of Jan Suykens. Son of Luc Bertrand (Bolero) |
Piet Dejonghe | Co-CEO; Co-Chairman of the Executive Committee | 1,966 | Long-standing AvH executive (marine/contracting oversight). Co-CEO since 2022 |
Tom Bamelis | CFO; Executive Committee member | 1,966 | Group CFO |
Piet Bevernage | Executive Committee member | 1,968 | — |
André-Xavier Cooreman | Executive Committee member | 1,964 | — |
Koen Janssen | Executive Committee member | 1,970 | — |
An Herremans | Executive Committee member | 1,982 | — |
“—” = not publicly disclosed.
Directors' Remuneration
| Executive | Base salary (EUR) | Variable / bonus (EUR) | Total cash (EUR) |
|---|---|---|---|
Piet Dejonghe (Co-CEO) | 923,522 | 1,537,071 | 2,460,593 |
Board of Directors
| Director | Born | Notes |
|---|---|---|
Baron Luc Bertrand (Chair) | 1,951 | Former CEO, 1990–2016. Chair since 2016. Also chairs or has chaired DEME, CFE and SIPEF |
Jacques Delen | 1,949 | Delen family; former Delen Private Bank chairman. Mandate renewed for 1 year at the 2024 AGM |
Frederic van Haaren | 1,960 | Great-grandson of founder N. van Haaren (Forbes Belgium) |
Pierre Willaert | 1,959 | Renewed for 4 years at the 2024 AGM |
Julien Pestiaux | 1,962 | — |
Thierry van Baren | 1,967 | — |
Marion Debruyne | 1,972 | Renewed for 4 years at the 2024 AGM |
Sonali Chandmal | 1,968 | — |
Victoria Vandeputte | 1,971 | — |
Bart Deckers | 1,978 | — |
Deborah Janssens | 1,975 | — |
Frank Van Lierde | 1,963 | — |
Board & Management Changes
| Date | Change |
|---|---|
28-Feb-2022 | CEO Jan Suykens announces he will hand over. John-Eric Bertrand and Piet Dejonghe become co-CEOs in 2022 |
2024 AGM (27-May-2024) | Renewals of J. Delen (1 year), P. Willaert (4 years) and M. Debruyne (4 years). Auditor appointed for 3 years |
26-May-2026 AGM | All agenda items approved. Specific director changes not detailed in sources reviewed |
Major Shareholders
| Holder | Stake (%) | Source |
|---|---|---|
Scaldis Invest NV (Belfimas / Celfloor chain) | 33.3 | boerse.de; Beursgenoten; transparency filings |
Treasury shares (30-Jun-2026) | 1.49 | H1-26 PR |
Free float | about 65.2 | Derived |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Positioning of AvH asset |
|---|---|---|
Listed holdings | Groupe Bruxelles Lambert (GBL), Sofina, Gimv, Brederode, Compagnie du Bois Sauvage, Exor, Investor AB, Industrivärden, Wendel, Peugeot Invest, HAL Trust | AvH is more operationally concentrated (controlling stakes) and earns consolidated profits rather than NAV marks. It has a lower dividend yield than GBL |
Dredging and marine infrastructure | Royal Boskalis (HAL), Jan De Nul (private), Van Oord (private), China Communications Construction (CHEC / Shanghai Dredging) | DEME is one of the "big four" Western dredgers, with similar scale to Boskalis |
Offshore-wind installation | Cadeler, Seaway7 / Subsea7, Van Oord, Jan De Nul, Boskalis, Saipem | DEME is a leading Tier-1 installer with an enlarged jack-up fleet after Havfram |
Belgian construction | BESIX, Jan De Nul (construction), Willemen, Strabag Belgium, Eiffage Benelux | CFE is mid-sized, with a niche in technical installations (VMA) |
Private banking (Belgium) | BNP Paribas Fortis Private Banking, KBC Private Banking, ING Private Banking, Degroof Petercam (now Indosuez), Puilaetco / Quintet | Delen is the largest discretionary manager in Belgium (Delen) with a 41% cost-income ratio |
Private banking (Netherlands / UK) | ABN AMRO MeesPierson, Van Lanschot Kempen, Rathbones, RBC Brewin Dolphin, Quilter | Delen NL is a fast-growing challenger; JM Finn is sub-scale (84% cost-income ratio) |
Belgian real estate | Cofinimmo, Befimmo, Atenor, Immobel, ION | Nextensa is a hybrid developer-investor, smaller than the leading REITs |
Palm oil | Socfin, SD Guthrie, Wilmar, Golden Agri-Resources, Astra Agro Lestari | SIPEF is a mid-sized, high-sustainability (RSPO) producer |
Supply-chain software (OMP) | Kinaxis, o9 Solutions, Blue Yonder, SAP IBP | Gartner MQ Leader |
Salmon (Grieg) | Mowi, SalMar, Lerøy, Cermaq | Grieg is a regional player (Rogaland) |
Peer Comparison FY2025
| Metric (FY2025) | AvH | GBL | Sofina | DEME (AvH sub) | Boskalis |
|---|---|---|---|---|---|
Revenue (EUR Mn) | 5,961.6 | — | — | 4,154.7 | 4,500 |
Revenue growth (%) | -1.4 | — | — | 1.3 | 2.3 |
EBITDA (EUR Mn) | 1,205.3 | — | — | 930.5 | 1,300 |
EBITDA margin (%) | 20.2 | — | — | 22.4 | 28.9 |
Net profit, group share (EUR Mn) | 592.5 | — | 113 | 346.3 | 775 |
NAV / book equity (EUR Bn) | 5.70 | 14.0 | 10.8 | 2.36 | — |
Recent Developments
*Also reported (date not confirmed in sources reviewed)
KBC Securities upgraded the stock to Buy and lifted its price target (MarketScreener feed, 2026).
DEME's MSCI ESG rating was upgraded to AA (H1 2026).
*Unclear dates
The Q3 2026 interim statement is listed for 1-Dec-2026 in the H1-26 PR, versus 26-Nov-2026 in the FY25 PR calendar. The later document is assumed current.



